1
2
Bosma, AL, de Wijs, Linde, Hof, MHP, van Nieuwenhuizen, BR, Gerbens, LAA, Middelkamp-Hup, MA, Hijnen, Dirk Jan, Spuls, PI
Veröffentlicht in: Bosma , AL , de Wijs , L , Hof , MHP , van Nieuwenhuizen , BR , Gerbens , LAA , Middelkamp-Hup , MA , Hijnen , D J & Spuls , PI 2020 , ' Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry ' , Journal of the American Academy of Dermatology , vol. 83 , no. 5 , pp. 1375-1384 . https://doi.org/10.1016/j.jaad.2020.05.128;
2020
Veröffentlicht in: Bosma , AL , de Wijs , L , Hof , MHP , van Nieuwenhuizen , BR , Gerbens , LAA , Middelkamp-Hup , MA , Hijnen , D J & Spuls , PI 2020 , ' Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry ' , Journal of the American Academy of Dermatology , vol. 83 , no. 5 , pp. 1375-1384 . https://doi.org/10.1016/j.jaad.2020.05.128;
2020
3
Geeven, I.P.A.C., Jessurun, N.T., Wasylewicz, A.T.M., Drent, M., Spuls, P.I., Hoentjen, F., van Puijenbroek, E.P., Vonkeman, H.E., Grootens, K.P., van Doorn, M.B.A., van den Bemt, B.J.F., Bekkers, C.L.
Veröffentlicht in: Geeven , I P A C , Jessurun , N T , Wasylewicz , A T M , Drent , M , Spuls , P I , Hoentjen , F , van Puijenbroek , E P , Vonkeman , H E , Grootens , K P , van Doorn , M B A , van den Bemt , B J F & Bekkers , C L 2022 , ' Barriers and facilitators for systematically registering adverse drug reactions in electronic health records: a qualitative study with Dutch healthcare professionals ' , Expert opinion on drug safety , vol. 21 , no. 5 , pp. 699-706 . https://doi.org/10.1080/14740338.2022.2020756;
2022
Veröffentlicht in: Geeven , I P A C , Jessurun , N T , Wasylewicz , A T M , Drent , M , Spuls , P I , Hoentjen , F , van Puijenbroek , E P , Vonkeman , H E , Grootens , K P , van Doorn , M B A , van den Bemt , B J F & Bekkers , C L 2022 , ' Barriers and facilitators for systematically registering adverse drug reactions in electronic health records: a qualitative study with Dutch healthcare professionals ' , Expert opinion on drug safety , vol. 21 , no. 5 , pp. 699-706 . https://doi.org/10.1080/14740338.2022.2020756;
2022